Coloplast Revises Financial Ambition Through 2030
Coloplast announced a revised financial ambition toward 2030. The headline also references FY 2026/27 guidance, but no guidance details are provided.
Related stories
Inspire Medical Systems reports Q3 EPS of -0.84
L impact | EARNINGS | Nov 02, 2026, 09:43 PM UTC
Apple Q4 26 Earnings
Rev: $114.48B (est $113.47B) EPS: $2.10 (est $2.00) Total Oper Expenses: $19.19B (est $19.19B) iPhone Rev: $57.58B (est $56.49B) Services Rev: $31.57B (est $31.58B) Mac Rev: $10.79
H impact | EARNINGS | Nov 02, 2026, 09:42 PM UTC
Cabot Reports Q4 Adjusted EPS of $1.61
Cabot reported Q4 net income of $66 million. Adjusted EPS was $1.61, versus the IBES estimate of $1.55.
M impact | EARNINGS | Nov 02, 2026, 09:37 PM UTC
California Resources Q3 Adjusted EPS Reaches $1.17
Q3 adjusted net income was $104 million, compared with the IBES estimate of $88.1 million.
M impact | EARNINGS | Nov 02, 2026, 09:36 PM UTC
EverQuote Sees Q4 2026 Adjusted EBITDA of $29M-$32M
M impact | EARNINGS | Nov 02, 2026, 09:33 PM UTC
Upwork Reports Q3 Adjusted EPS of $0.40
L impact | EARNINGS | Nov 02, 2026, 09:32 PM UTC